Nitric oxide donor hybrid compounds as promising anticancer agents

26Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Nitric oxide (NO) plays important roles in cardiovascular regulation, nerve transmission delivery and immune responses. In the last semicenturry, it has been proved that though low concentration of NO is tumor-promoting, high concentration of NO could exhibit multiple antitumor effects, which led to the research and development of kinds of NO donors and NO donor hybrid compounds as antitumor agents. Herein, the recent development of NO donor hybrid compounds is briefly reviewed.

Cite

CITATION STYLE

APA

Ding, Q. G., Zang, J., Gao, S., Gao, Q., Duan, W., Li, X., … Zhang, Y. (2017, January 15). Nitric oxide donor hybrid compounds as promising anticancer agents. Drug Discoveries & Therapeutics. https://doi.org/10.5582/ddt.2016.01067

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free